Testing a diabetes drug to help men quit smoking
Part of Hormones & metabolism, Mental health clinical trials.
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 75 years old.
- You have type 2 diabetes.
- You have smoked for at least one year.
- You have a moderate to high nicotine dependence (score of 4 or more on a standard test).
- You haven't taken GLP-1 receptor agonists or DPP-4 inhibitors before.
- You are willing to have an MRI scan (no metal implants, pacemaker, or claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the diabetes drug semaglutide can help people with type 2 diabetes stop smoking more easily. Participants will get either semaglutide or a placebo to see if it improves quit rates.
This study tests whether tirzepatide, a medication that helps with weight and blood sugar, can also help people quit smoking. You'd receive the medication plus standard quitting support (nicotine patches or gum and a quit-smoking app) over several months.
This trial is testing whether a GLP-1 receptor agonist (a medicine used for diabetes) helps treat gum disease (periodontitis) in people with type 2 diabetes. It might show that this medication improves gum health as a side benefit.
This study tests a program that helps people with HIV quit smoking by combining medication, counseling, and financial rewards. It aims to see if this approach works well in HIV clinics and helps reduce smoking.
This study tests whether the drug semaglutide (often used for weight loss) can help people who quit smoking avoid gaining weight. It's for people who are overweight or have weight-related health issues and want to stop smoking.
This study tests whether the medication semaglutide (similar to Ozempic/Wegovy) can help people who smoke and have obesity cut down on cigarettes, even if they aren't ready to quit. Participants will receive the drug and be monitored for changes in smoking habits and health.
Hear when a new Nicotine Dependence, Cigarettes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.